Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001641172-25-007878
Filing Date
2025-04-30
Accepted
2025-04-30 17:10:30
Documents
90

Document Format Files

Seq Description Document Type Size
1 formposam.htm   iXBRL POS AM 2664836
2 ex23-1.htm EX-23.1 3719
3 forms-1_001.jpg GRAPHIC 10244
4 posam_001.jpg GRAPHIC 90910
5 formposam_011.jpg GRAPHIC 27825
6 formposam_012.jpg GRAPHIC 31022
7 formposam_013.jpg GRAPHIC 47934
8 formposam_014.jpg GRAPHIC 86641
9 posam_002.jpg GRAPHIC 42067
10 formposam_016.jpg GRAPHIC 14757
11 formposam_017.jpg GRAPHIC 46295
12 formposam_018.jpg GRAPHIC 33253
  Complete submission text file 0001641172-25-007878.txt   9549742

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE tvgn-20241231.xsd EX-101.SCH 51878
14 XBRL CALCULATION FILE tvgn-20241231_cal.xml EX-101.CAL 74153
15 XBRL DEFINITION FILE tvgn-20241231_def.xml EX-101.DEF 283562
16 XBRL LABEL FILE tvgn-20241231_lab.xml EX-101.LAB 414466
17 XBRL PRESENTATION FILE tvgn-20241231_pre.xml EX-101.PRE 358833
93 EXTRACTED XBRL INSTANCE DOCUMENT formposam_htm.xml XML 1041269
Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Filer) CIK: 0001860871 (see all company filings)

EIN.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-280414 | Film No.: 25897407
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)